Mabcampath and pneumonia Patient Reports February 11, 2012

Mabcampath Side Effects Report #6068436-3
Mabcampath side effect was reported by a Physician from BELGIUM on Jan 29, 2009. Male patient, 61 years of age, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: chronic lymphocytic leukaemia transformation, diffuse large b-cell lymphoma, febrile neutropenia, pancytopenia, pneumonia . Mabcampath dosage: unknown. Patient recovered.

Mabcampath Side Effects Report #5993328-5
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Dec 05, 2008. Male patient, 67 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, febrile neutropenia, pneumonia , thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 11/13/2008.

Mabcampath Side Effects Report #6017147-9
Mabcampath side effect was reported by a Physician from FRANCE on Dec 05, 2008. Male patient, 67 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, febrile neutropenia, pneumonia , thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 11/13/2008.

Mabcampath Side Effects Report #6070451-0
Mabcampath side effect was reported by a Physician from FRANCE on Feb 05, 2009. Male patient, 67 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, febrile neutropenia, pneumonia , thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 11/13/2008.